The goal of the work described in this proposal is to understand the molecular mechanisms involved in the regulation of gene expression at the levels of transcription elongation, termination and antitermination. The level at which genes are expressed, as well as the level at which the resulting transcripts are utilized to produce functional gene products, are both regulated by specific protein-nucleic acid interactions. Events which alter gene regulation can cause inappropriate expression of viral and/or cancerous genes. In addition, some viral proteins reprogram host transcriptional machinery to allow expression of viral genes. If the mechanisms involved in the regulation of gene expression can be characterized, at the level of specific protein-nucleic acid interactions, it then becomes possible to mimic or prevent the action of viral proteins, for example. Detailed analysis of the steps involved in RNA synthesis, or transcription, can eventually lead to strategies for controlling gene expression through specific drug design. This proposal is focused on understanding how a viral protein can reprogram a host RNA polymerase to allow expression of viral genes. Specifically, the mechanism utilized by the bacteriophage lambda to accomplish expression of its late viral genes is being examined. Late gene expression involves modification of the RNA polymerase of the host, Escherichia coli, by the viral antitermination protein Q, to render the polymerase resistant to transcription termination signals. The Q protein recruits at least one host protein, NusA, which normally increases termination efficiency in E. coli. The molecular modifications which occur to reprogram the host polymerase, and to cause a host factor which normally causes termination to participate in antitermination, will be determined by characterizing the specific molecular interactions in the antitermination complex. The bacterium E. coli is an ideal model system for analysis of the molecular mechanisms employed by viral proteins. Transcription can be reconstituted in vitro utilizing purified RNA polymerase and transcription factors. In such a purified system, it is also possible to test methods for inhibiting the action of viral proteins to prevent modification of the transcription process. Molecular interactions are being characterized by using photochemical crosslinking. Photocrosslinker tagged nucleotide analogs will be used to identify interactions with the DNA and/or RNA components in different transcription complexes. Heterobifunctional crosslinkers will be used to characterize the protein-protein interactions. Both unmodified transcription complexes, and those that have been altered by the viral Q protein will be examined and compared, with the goal of better understanding how modification is accomplished. Data obtained in this model system can lead to a greater understanding of the different ways in which viral proteins function, and may lead to greater understanding of mechanisms in more complex systems.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM047493-07
Application #
2838595
Study Section
Microbial Physiology and Genetics Subcommittee 2 (MBC)
Program Officer
Tompkins, Laurie
Project Start
1991-09-01
Project End
1999-08-15
Budget Start
1998-12-01
Budget End
1999-08-15
Support Year
7
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Oklahoma Norman
Department
Other Basic Sciences
Type
Schools of Arts and Sciences
DUNS #
848348348
City
Norman
State
OK
Country
United States
Zip Code
73019
Costas, C; Yuriev, E; Meyer, K L et al. (2000) RNA-protein crosslinking to AMP residues at internal positions in RNA with a new photocrosslinking ATP analog. Nucleic Acids Res 28:1849-58
Hanna, M M; Bentsen, L; Lucido, M et al. (1999) RNA-protein crosslinking with photoreactive nucleotide analogs. Methods Mol Biol 118:21-33
Hanna, M M; Yuriev, E; Zhang, J et al. (1999) Probing the environment of nascent RNA in Escherichia coli transcription elongation complexes utilizing a new fluorescent ribonucleotide analog. Nucleic Acids Res 27:1369-76
Hanna, M M; Liu, K (1998) Nascent RNA in transcription complexes interacts with CspE, a small protein in E. coli implicated in chromatin condensation. J Mol Biol 282:227-39
Liu, K; Hanna, M M (1995) NusA interferes with interactions between the nascent RNA and the C-terminal domain of the alpha subunit of RNA polymerase in Escherichia coli transcription complexes. Proc Natl Acad Sci U S A 92:5012-6
He, B; Riggs, D L; Hanna, M M (1995) Preparation of probe-modified RNA with 5-mercapto-UTP for analysis of protein-RNA interactions. Nucleic Acids Res 23:1231-8
Liu, K; Hanna, M M (1995) NusA contacts nascent RNA in Escherichia coli transcription complexes. J Mol Biol 247:547-58
Zhang, Y; Hanna, M M (1994) NusA changes the conformation of Escherichia coli RNA polymerase at the binding site for the 3' end of the nascent RNA. J Bacteriol 176:1787-9
Hanna, M M (1993) Photocrosslinking analysis of protein-RNA interactions in E. coli transcription complexes. Cell Mol Biol Res 39:393-9